CCDC150
gene geneOn this page
Also known as FLJ39660
Summary
CCDC150 (coiled-coil domain containing 150, HGNC:26834) is a protein-coding gene on chromosome 2q33.1, encoding Coiled-coil domain-containing protein 150 (Q8NCX0).
At a glance
- Clinical variants (ClinVar): 190 total
- MANE Select transcript:
NM_001080539
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26834 |
| Approved symbol | CCDC150 |
| Name | coiled-coil domain containing 150 |
| Location | 2q33.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ39660 |
| Ensembl gene | ENSG00000144395 |
| Ensembl biotype | protein_coding |
| Entrez | 284992 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 11 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay, 3 retained_intron, 2 protein_coding
ENST00000389175, ENST00000409270, ENST00000424427, ENST00000431807, ENST00000448409, ENST00000460114, ENST00000461243, ENST00000461825, ENST00000463826, ENST00000465092, ENST00000469429, ENST00000471033, ENST00000471546, ENST00000483877, ENST00000487663, ENST00000494389, ENST00000495513, ENST00000497159, ENST00000498512
RefSeq mRNA: 4 — MANE Select: NM_001080539
NM_001080539, NM_001353339, NM_001353340, NM_001412753
CCDS: CCDS46478
Canonical transcript exons
ENST00000389175 — 28 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002207185 | 196732446 | 196732801 |
| ENSE00002237029 | 196712677 | 196712739 |
| ENSE00002323999 | 196666719 | 196666848 |
| ENSE00003472395 | 196639715 | 196639778 |
| ENSE00003476453 | 196656958 | 196657136 |
| ENSE00003480417 | 196701109 | 196701180 |
| ENSE00003497857 | 196656633 | 196656853 |
| ENSE00003501404 | 196646341 | 196646504 |
| ENSE00003510984 | 196725973 | 196726099 |
| ENSE00003511093 | 196719497 | 196719666 |
| ENSE00003517647 | 196729957 | 196730118 |
| ENSE00003530345 | 196672345 | 196672437 |
| ENSE00003532913 | 196718503 | 196718631 |
| ENSE00003537971 | 196732033 | 196732152 |
| ENSE00003539109 | 196677293 | 196677361 |
| ENSE00003546629 | 196674241 | 196674348 |
| ENSE00003553016 | 196676143 | 196676267 |
| ENSE00003575279 | 196712145 | 196712252 |
| ENSE00003602423 | 196676554 | 196676731 |
| ENSE00003603409 | 196720575 | 196720668 |
| ENSE00003608774 | 196729193 | 196729387 |
| ENSE00003618097 | 196658792 | 196658860 |
| ENSE00003623872 | 196669833 | 196669876 |
| ENSE00003630692 | 196665567 | 196665683 |
| ENSE00003632804 | 196730859 | 196730945 |
| ENSE00003657674 | 196695046 | 196695159 |
| ENSE00003664591 | 196721522 | 196721691 |
| ENSE00003679053 | 196729793 | 196729861 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 93.04.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.2435 / max 152.9024, expressed in 954 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 24461 | 3.5867 | 836 |
| 24460 | 0.6513 | 366 |
| 24462 | 0.0055 | 3 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 93.04 | gold quality |
| left testis | UBERON:0004533 | 90.63 | gold quality |
| right testis | UBERON:0004534 | 90.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.21 | gold quality |
| sperm | CL:0000019 | 88.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.82 | gold quality |
| testis | UBERON:0000473 | 88.29 | gold quality |
| ventricular zone | UBERON:0003053 | 82.22 | gold quality |
| right lobe of liver | UBERON:0001114 | 80.72 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.67 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.30 | silver quality |
| sural nerve | UBERON:0015488 | 76.58 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.32 | gold quality |
| kidney epithelium | UBERON:0004819 | 74.50 | gold quality |
| liver | UBERON:0002107 | 73.17 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.90 | gold quality |
| bone marrow cell | CL:0002092 | 72.06 | gold quality |
| secondary oocyte | CL:0000655 | 71.88 | silver quality |
| esophagus mucosa | UBERON:0002469 | 71.75 | gold quality |
| cortex of kidney | UBERON:0001225 | 70.85 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 70.72 | gold quality |
| rectum | UBERON:0001052 | 70.62 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 70.41 | gold quality |
| calcaneal tendon | UBERON:0003701 | 69.58 | gold quality |
| skin of leg | UBERON:0001511 | 69.10 | gold quality |
| right uterine tube | UBERON:0001302 | 68.99 | gold quality |
| bone marrow | UBERON:0002371 | 68.95 | gold quality |
| skin of abdomen | UBERON:0001416 | 68.24 | gold quality |
| vermiform appendix | UBERON:0001154 | 68.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.44 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting CCDC150, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-154-3P | 99.50 | 70.05 | 831 |
| HSA-MIR-487A-3P | 99.50 | 69.95 | 840 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-2116-5P | 99.32 | 69.34 | 1273 |
| HSA-MIR-8066 | 99.05 | 68.66 | 1532 |
| HSA-MIR-4483 | 98.09 | 64.12 | 1642 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-3936 | 97.64 | 64.47 | 732 |
| HSA-MIR-4475 | 97.36 | 66.95 | 761 |
| HSA-MIR-122-5P | 97.23 | 64.92 | 1024 |
| HSA-MIR-1293 | 96.16 | 64.69 | 916 |
| HSA-MIR-9900 | 96.06 | 65.48 | 557 |
| HSA-MIR-3927-5P | 94.90 | 68.11 | 399 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-75b17.1 | ENSDARG00000090935 |
| mus_musculus | Ccdc150 | ENSMUSG00000025983 |
| rattus_norvegicus | Ccdc150 | ENSRNOG00000013318 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 150 — Q8NCX0 (reviewed: Q8NCX0)
All UniProt accessions (4): Q8NCX0, B8ZZI4, E9PCV3, F8WCU1
UniProt curated annotations — full annotation on UniProt →
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NCX0-1 | 1 | yes |
| Q8NCX0-2 | 2 | |
| Q8NCX0-3 | 3 | |
| Q8NCX0-4 | 4 |
RefSeq proteins (4): NP_001074008, NP_001340268, NP_001340269, NP_001399682 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038807 | CCDC150 | Family |
UniProt features (17 total): splice variant 7, coiled-coil region 4, sequence conflict 2, chain 1, region of interest 1, sequence variant 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NCX0-F1 | 74.19 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 63 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP, GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, AACYNNNNTTCCS_UNKNOWN, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, HOOI_ST7_TARGETS_DN, FISCHER_DREAM_TARGETS, TCCCRNNRTGC_UNKNOWN, MARSON_BOUND_BY_E2F4_UNSTIMULATED, WHITFIELD_CELL_CYCLE_S, ZWANG_DOWN_BY_2ND_EGF_PULSE, HSD17B8_TARGET_GENES, MAFG_TARGET_GENES, NKX2_2_TARGET_GENES, SALL4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
452 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC150 | ARMH2 | H3BNL8 | 581 |
| CCDC150 | J3KS56 | J3KS56 | 577 |
| CCDC150 | CCDC77 | Q9BR77 | 572 |
| CCDC150 | GTF3C3 | Q9Y5Q9 | 559 |
| CCDC150 | CEP15 | Q9HBI5 | 559 |
| CCDC150 | C9orf40 | Q8IXQ3 | 556 |
| CCDC150 | NEMP1 | O14524 | 542 |
| CCDC150 | CEP85 | Q6P2H3 | 534 |
| CCDC150 | CCDC34 | Q96HJ3 | 530 |
| CCDC150 | REEP4 | Q9H6H4 | 528 |
| CCDC150 | UBALD2 | Q8IYN6 | 516 |
| CCDC150 | IQCK | Q8N0W5 | 514 |
| CCDC150 | GSTCD | Q8NEC7 | 507 |
| CCDC150 | DEPDC1B | Q8WUY9 | 490 |
| CCDC150 | ZNF367 | Q7RTV3 | 489 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC150 | NUP62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA2 | CCDC150 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFHC1 | SRM | psi-mi:“MI:0914”(association) | 0.510 |
| CCDC150 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFHC1 | CCDC150 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RAD50 | CCDC150 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): CCDC150 (Two-hybrid), CCDC150 (Two-hybrid), CCDC150 (Affinity Capture-MS), C15orf26 (Affinity Capture-MS), CCDC150 (Affinity Capture-MS), CCDC150 (Proximity Label-MS), CCDC150 (Two-hybrid), CCDC150 (Two-hybrid), EAF1 (Two-hybrid), PRPF18 (Two-hybrid), GOLGA2 (Two-hybrid), CCDC150 (Affinity Capture-MS), CCDC150 (Cross-Linking-MS (XL-MS)), EEA1 (Cross-Linking-MS (XL-MS)), KLHL2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A2R8QCI3, A3KGV1, A3KNA5, A7MD70, B1WB65, B8JK76, F6ZDS4, G5E861, O35550, O35551, P55937, P85001, Q08DR9, Q15276, Q2T9U2, Q4R6W3, Q4R703, Q4R8C3, Q502I3, Q5BJF6, Q5M9N0, Q5PQ23, Q5PR68, Q5R829, Q5RG45, Q5ZKK5, Q66GS9, Q66KE8, Q6AYX5, Q6NRC9, Q6NRW2, Q6NY15, Q6P5D4, Q6ZU80, Q80UF4, Q811U3, Q86SQ7, Q8BI22, Q8CDI6, Q8CDI7
Diamond homologs: Q8CDI7, Q8NCX0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
190 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 164 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4495 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:196639778:GGT:G | donor_loss | 1.0000 |
| 2:196658790:A:AG | acceptor_gain | 1.0000 |
| 2:196658791:G:GA | acceptor_gain | 1.0000 |
| 2:196658791:GA:G | acceptor_gain | 1.0000 |
| 2:196658791:GAA:G | acceptor_gain | 1.0000 |
| 2:196658791:GAAGA:G | acceptor_gain | 1.0000 |
| 2:196658857:AGAGG:A | donor_loss | 1.0000 |
| 2:196658858:GAG:G | donor_gain | 1.0000 |
| 2:196658859:AGGT:A | donor_loss | 1.0000 |
| 2:196658862:T:G | donor_loss | 1.0000 |
| 2:196666842:GATC:G | donor_gain | 1.0000 |
| 2:196666845:C:CG | donor_gain | 1.0000 |
| 2:196666845:C:G | donor_gain | 1.0000 |
| 2:196672438:G:GG | donor_gain | 1.0000 |
| 2:196676134:A:AG | acceptor_gain | 1.0000 |
| 2:196676135:A:G | acceptor_gain | 1.0000 |
| 2:196676136:C:G | acceptor_gain | 1.0000 |
| 2:196676137:A:AG | acceptor_gain | 1.0000 |
| 2:196676138:C:G | acceptor_gain | 1.0000 |
| 2:196676139:TCAG:T | acceptor_loss | 1.0000 |
| 2:196676140:CA:C | acceptor_loss | 1.0000 |
| 2:196676141:A:AG | acceptor_gain | 1.0000 |
| 2:196676142:G:GG | acceptor_gain | 1.0000 |
| 2:196676142:G:GT | acceptor_loss | 1.0000 |
| 2:196676142:GGT:G | acceptor_gain | 1.0000 |
| 2:196676142:GGTA:G | acceptor_gain | 1.0000 |
| 2:196676263:CATCT:C | donor_gain | 1.0000 |
| 2:196676264:ATCT:A | donor_gain | 1.0000 |
| 2:196676265:TCT:T | donor_gain | 1.0000 |
| 2:196676265:TCTG:T | donor_loss | 1.0000 |
AlphaMissense
7360 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:196719561:T:C | L687S | 0.991 |
| 2:196719527:G:C | A676P | 0.989 |
| 2:196719573:T:C | L691P | 0.985 |
| 2:196719603:T:C | L701P | 0.985 |
| 2:196719581:C:G | H694D | 0.984 |
| 2:196719578:T:C | S693P | 0.982 |
| 2:196719624:T:C | L708P | 0.982 |
| 2:196721586:T:C | L775P | 0.982 |
| 2:196719654:T:C | L718P | 0.978 |
| 2:196721574:T:C | L771P | 0.977 |
| 2:196721598:T:C | L779P | 0.974 |
| 2:196719583:C:A | H694Q | 0.973 |
| 2:196719583:C:G | H694Q | 0.973 |
| 2:196729997:T:C | L954P | 0.973 |
| 2:196721616:T:C | L785P | 0.972 |
| 2:196729257:T:C | L874P | 0.972 |
| 2:196720604:T:C | L732P | 0.971 |
| 2:196719582:A:C | H694P | 0.970 |
| 2:196719591:T:C | M697T | 0.967 |
| 2:196719561:T:G | L687W | 0.966 |
| 2:196721594:G:C | A778P | 0.965 |
| 2:196719575:G:C | A692P | 0.964 |
| 2:196719570:T:A | V690E | 0.963 |
| 2:196729214:G:C | A860P | 0.963 |
| 2:196721576:G:C | A772P | 0.960 |
| 2:196719564:A:T | E688V | 0.959 |
| 2:196719599:G:C | A700P | 0.959 |
| 2:196732066:T:C | F1035L | 0.958 |
| 2:196732068:T:A | F1035L | 0.958 |
| 2:196732068:T:G | F1035L | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000020127 (2:196693615 C>T), RS1000057212 (2:196648633 T>C), RS1000082844 (2:196669148 A>G), RS1000119123 (2:196664430 A>G), RS1000148976 (2:196688360 A>G), RS1000264319 (2:196694549 C>G), RS1000297890 (2:196706925 G>A), RS1000353666 (2:196637820 G>A,C), RS1000396465 (2:196706681 A>G), RS1000427859 (2:196711665 C>A), RS1000474228 (2:196718783 A>G), RS1000500210 (2:196668025 C>A,T), RS1000501720 (2:196675642 A>G), RS1000517953 (2:196687337 T>C), RS1000533076 (2:196648347 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression, increases expression | 3 |
| Arsenic | increases methylation, decreases expression, increases abundance | 2 |
| Silicon Dioxide | increases expression, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression, increases methylation | 2 |
| Cyclosporine | decreases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| titanium dioxide | decreases expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Latex | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Gold Compounds | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D9B7 | Ubigene HEK293 CCDC150 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.